Cargando…
Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
PURPOSE: Patient-derived tumor xenografts (PDXs) can provide more reliable information about tumor biology than cell line models. We developed PDXs for epithelial ovarian cancer (EOC) that have histopathologic and genetic similarities to the primary patient tissues and evaluated their potential for...
Autores principales: | Heo, Eun Jin, Cho, Young Jae, Cho, William Chi, Hong, Ji Eun, Jeon, Hye-Kyung, Oh, Doo-Yi, Choi, Yoon-La, Song, Sang Yong, Choi, Jung-Joo, Bae, Duk-Soo, Lee, Yoo-Young, Choi, Chel Hun, Kim, Tae-Joong, Park, Woong-Yang, Kim, Byoung-Gie, Lee, Jeong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654149/ https://www.ncbi.nlm.nih.gov/pubmed/28052650 http://dx.doi.org/10.4143/crt.2016.322 |
Ejemplares similares
-
Catamenial hemoptysis accompanied by subcutaneous endometriosis treated with combination therapy
por: Jang, Hye-In, et al.
Publicado: (2017) -
Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020) -
Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013) -
Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015) -
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)